Continuous Low-Dose Infusion of Human Atrial Natriuretic Peptide in Patients With Left Ventricular Dysfunction Undergoing Coronary Artery Bypass Grafting
Akira Sezai(Nihon University), Kazutomo Minami(Nihon University), Isamu Yoshitake(Nihon University), Yuji Kasamaki(Nihon University), Tetsuya Niino(Nihon University), Mitsumasa Hata(Nihon University), Tadateru Takayama(Nihon University), K Fujita(Nihon University), Atsushi Hirayama(Nihon University), Shinji Wakui(Nihon University), Satoshi Unosawa(Nihon University)
Cited by 77
Related Papers
High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD)
|Circulation|2018|242
Comparison of Febuxostat and Allopurinol for Hyperuricemia in Cardiac Surgery Patients (NU-FLASH Trial)
|Circulation Journal|2013|120
Effects of Canagliflozin in Patients with Type 2 Diabetes and Chronic Heart Failure: A Randomized Trial (CANDLE)
|ESC Heart Failure|2020|109
Results of Low-Dose Human Atrial Natriuretic Peptide Infusion in Nondialysis Patients With Chronic Kidney Disease Undergoing Coronary Artery Bypass Grafting
|Journal of the American College of Cardiology|2011|108